Document Detail

Development and implementation of a quality assurance program for a hormonal contraceptive implant.
MedLine Citation:
PMID:  22921687     Owner:  NLM     Status:  Publisher    
BACKGROUND: The importance of the distribution of safe, effective and cost-effective pharmaceutical products in resource-constrained countries is the subject of increasing attention. FHI 360 has developed a program aimed at evaluating the quality of a contraceptive implant manufactured in China, while the product is being registered in an increasing number of countries and distributed by international procurement agencies. The program consists of (1) independent product testing; (2) ongoing evaluation of the manufacturing facility through audits and inspections; and (3) post-marketing surveillance. STUDY DESIGN: This article focuses on the laboratory testing of the product. The various test methods were chosen from the following test method compendia, the United States Pharmacopeia (USP), British Pharmacopeia (BP), International Organization for Standardization (ISO), the American Society for Testing and Materials (ASTM), or lot release tests mandated by Chinese regulatory requirements. Each manufactured lot is independently tested prior to its distribution to countries supported by this program. In addition, a more detailed annual testing program includes evaluation of the active ingredient (levonorgestrel), the final product and the packaging material. RESULTS: Over the first 4 years of this 5-year project, all tested lots met the established quality criteria. CONCLUSIONS: The quality assurance program developed for this contraceptive implant has helped ensure that a safe product was being introduced into developing country family planning programs. This program provides a template for establishing quality assurance programs for other cost-effective pharmaceutical products that have not yet received stringent regulatory approval and are being distributed in resource-poor settings.
Derek H Owen; David Jenkins; Aida Cancel; Eli Carter; Laneta Dorflinger; Jeff Spieler; Markus J Steiner
Related Documents :
4006717 - How can pharmacists develop and implement a home antibiotic program?
24558277 - The health sciences reasoning test in the pharmacy admissions process.
16492997 - Evaluation and communication: using a communication audit to evaluate organizational co...
20155237 - Subjective outcome evaluation of the project p.a.t.h.s: descriptive profiles and correl...
11587907 - Pilot test of an internet virtual world chat room for rural teen smokers.
15890597 - 2003 survey of canadian radiation oncology residents.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-23
Journal Detail:
Title:  Contraception     Volume:  -     ISSN:  1879-0518     ISO Abbreviation:  Contraception     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0234361     Medline TA:  Contraception     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
FHI 360, P.O. Box 13950, Research Triangle Park, NC 27709, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Computer-assisted provision of hormonal contraception in acute care settings.
Next Document:  A physiotherapist-delivered, combined exercise and pain coping skills training intervention for indi...